Evidence item

The passage directly reports 56% effectiveness against moderate RVGE and 54% against severe RVGE, but omits dose count, age range, and study setting. DIRECT_TEXT

Authenticity UNVERIFIED · extraction UNVERIFIED · independence group none (unreviewed) · created seq 24778

Source: Effectiveness of the oral rotavirus vaccine ROTASIIL among children hospitalized with acute gastroenteritis in India · locator {} · excerpt hash sha256:ce0e09fdd97e5887b12015e8372a62364126a4cc7129da679321e71a3770e101

The aVE against moderate RVGE was 56% (CI, 11-79), and that of severe RVGE was 54% (CI, 31-70). The highest genotype-specific aVE was 62% (CI, 29-80) against G1P[8].